Dry Eye
Conditions
Brief summary
To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.
Interventions
DRUGOptive
Sponsors
Innovative Medical
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
* · Dry eye disease diagnosis * Patients must currently be using Systane tears at least once a day and for at least 1 month. * Normal lid position and closure * Male or female of legal age of consent * Informed consent has been obtained * Likely to complete all required follow-up visits
Exclusion criteria
* · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study. * Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.
Countries
United States
Outcome results
None listed